Chemerin levels are positively correlated with abdominal visceral fat accumulation

Hyun Young Shin, Duk C. Lee, Sang H. Chu, Justin Y. Jeon, Mi K. Lee, Jee A. Im, Ji Won Lee

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Objective: Chemerin, a recently discovered adipocytokine, may be linked to obesity and obesity-associated metabolic complications. However, the relationship between visceral fat accumulation and chemerin is still unknown. Therefore, we investigated the relationship between serum chemerin levels and body composition as measured by computed tomography (CT). Patients: We recruited 173 men and women without histories of diabetes or cardiovascular disease. Measurements: Biomarkers of metabolic risk factors and body composition by computed tomography were assessed. Serum chemerin levels were measured by enzyme-linked immunosorbent assay. Results: Chemerin levels correlated with body mass index (BMI), waist circumference, abdominal visceral fat area, blood pressure, fasting insulin, homoeostasis model of assessment-insulin resistance, total cholesterol, triglyceride, creatinine, aspartate aminotransferase and alanine aminotransferase. By stepwise multiple regression analysis, abdominal visceral fat area, blood pressure and total cholesterol levels independently affected chemerin levels. Conclusions: Abdominal visceral fat accumulation, blood pressure and lipid profile were significantly associated with serum chemerin levels. Our findings suggest that chemerin may be a mediator that links visceral obesity to cardiovascular risk factors.

Original languageEnglish
Pages (from-to)47-50
Number of pages4
JournalClinical Endocrinology
Volume77
Issue number1
DOIs
Publication statusPublished - 2012 Jul 1

Fingerprint

Intra-Abdominal Fat
Blood Pressure
Body Composition
Obesity
Serum
Cholesterol
Tomography
Adipokines
Abdominal Obesity
Waist Circumference
Aspartate Aminotransferases
Alanine Transaminase
Insulin Resistance
Fasting
Creatinine
Triglycerides
Body Mass Index
Homeostasis
Cardiovascular Diseases
Biomarkers

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Shin, Hyun Young ; Lee, Duk C. ; Chu, Sang H. ; Jeon, Justin Y. ; Lee, Mi K. ; Im, Jee A. ; Lee, Ji Won. / Chemerin levels are positively correlated with abdominal visceral fat accumulation. In: Clinical Endocrinology. 2012 ; Vol. 77, No. 1. pp. 47-50.
@article{55888125e72e477c8c07dc222edf317d,
title = "Chemerin levels are positively correlated with abdominal visceral fat accumulation",
abstract = "Objective: Chemerin, a recently discovered adipocytokine, may be linked to obesity and obesity-associated metabolic complications. However, the relationship between visceral fat accumulation and chemerin is still unknown. Therefore, we investigated the relationship between serum chemerin levels and body composition as measured by computed tomography (CT). Patients: We recruited 173 men and women without histories of diabetes or cardiovascular disease. Measurements: Biomarkers of metabolic risk factors and body composition by computed tomography were assessed. Serum chemerin levels were measured by enzyme-linked immunosorbent assay. Results: Chemerin levels correlated with body mass index (BMI), waist circumference, abdominal visceral fat area, blood pressure, fasting insulin, homoeostasis model of assessment-insulin resistance, total cholesterol, triglyceride, creatinine, aspartate aminotransferase and alanine aminotransferase. By stepwise multiple regression analysis, abdominal visceral fat area, blood pressure and total cholesterol levels independently affected chemerin levels. Conclusions: Abdominal visceral fat accumulation, blood pressure and lipid profile were significantly associated with serum chemerin levels. Our findings suggest that chemerin may be a mediator that links visceral obesity to cardiovascular risk factors.",
author = "Shin, {Hyun Young} and Lee, {Duk C.} and Chu, {Sang H.} and Jeon, {Justin Y.} and Lee, {Mi K.} and Im, {Jee A.} and Lee, {Ji Won}",
year = "2012",
month = "7",
day = "1",
doi = "10.1111/j.1365-2265.2011.04217.x",
language = "English",
volume = "77",
pages = "47--50",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "1",

}

Chemerin levels are positively correlated with abdominal visceral fat accumulation. / Shin, Hyun Young; Lee, Duk C.; Chu, Sang H.; Jeon, Justin Y.; Lee, Mi K.; Im, Jee A.; Lee, Ji Won.

In: Clinical Endocrinology, Vol. 77, No. 1, 01.07.2012, p. 47-50.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chemerin levels are positively correlated with abdominal visceral fat accumulation

AU - Shin, Hyun Young

AU - Lee, Duk C.

AU - Chu, Sang H.

AU - Jeon, Justin Y.

AU - Lee, Mi K.

AU - Im, Jee A.

AU - Lee, Ji Won

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Objective: Chemerin, a recently discovered adipocytokine, may be linked to obesity and obesity-associated metabolic complications. However, the relationship between visceral fat accumulation and chemerin is still unknown. Therefore, we investigated the relationship between serum chemerin levels and body composition as measured by computed tomography (CT). Patients: We recruited 173 men and women without histories of diabetes or cardiovascular disease. Measurements: Biomarkers of metabolic risk factors and body composition by computed tomography were assessed. Serum chemerin levels were measured by enzyme-linked immunosorbent assay. Results: Chemerin levels correlated with body mass index (BMI), waist circumference, abdominal visceral fat area, blood pressure, fasting insulin, homoeostasis model of assessment-insulin resistance, total cholesterol, triglyceride, creatinine, aspartate aminotransferase and alanine aminotransferase. By stepwise multiple regression analysis, abdominal visceral fat area, blood pressure and total cholesterol levels independently affected chemerin levels. Conclusions: Abdominal visceral fat accumulation, blood pressure and lipid profile were significantly associated with serum chemerin levels. Our findings suggest that chemerin may be a mediator that links visceral obesity to cardiovascular risk factors.

AB - Objective: Chemerin, a recently discovered adipocytokine, may be linked to obesity and obesity-associated metabolic complications. However, the relationship between visceral fat accumulation and chemerin is still unknown. Therefore, we investigated the relationship between serum chemerin levels and body composition as measured by computed tomography (CT). Patients: We recruited 173 men and women without histories of diabetes or cardiovascular disease. Measurements: Biomarkers of metabolic risk factors and body composition by computed tomography were assessed. Serum chemerin levels were measured by enzyme-linked immunosorbent assay. Results: Chemerin levels correlated with body mass index (BMI), waist circumference, abdominal visceral fat area, blood pressure, fasting insulin, homoeostasis model of assessment-insulin resistance, total cholesterol, triglyceride, creatinine, aspartate aminotransferase and alanine aminotransferase. By stepwise multiple regression analysis, abdominal visceral fat area, blood pressure and total cholesterol levels independently affected chemerin levels. Conclusions: Abdominal visceral fat accumulation, blood pressure and lipid profile were significantly associated with serum chemerin levels. Our findings suggest that chemerin may be a mediator that links visceral obesity to cardiovascular risk factors.

UR - http://www.scopus.com/inward/record.url?scp=84862011803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862011803&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2265.2011.04217.x

DO - 10.1111/j.1365-2265.2011.04217.x

M3 - Article

C2 - 21895733

AN - SCOPUS:84862011803

VL - 77

SP - 47

EP - 50

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 1

ER -